Undressing of phosphine gold(I) complexes as irreversible inhibitors of human disulfide reductases.
about
Inhibition of Schistosoma mansoni thioredoxin-glutathione reductase by auranofin: structural and kinetic aspectsMetal- and Semimetal-Containing Inhibitors of Thioredoxin Reductase as Anticancer AgentsThe mode of action of anticancer gold-based drugs: a structural perspectiveInteractions of gold-based drugs with proteins: crystal structure of the adduct formed between ribonuclease A and a cytotoxic gold(III) compoundInteractions of gold-based drugs with proteins: the structure and stability of the adduct formed in the reaction between lysozyme and the cytotoxic gold(III) compound Auoxo3Structural evidences for a secondary gold binding site in the hydrophobic box of lysozymeGold compounds as therapeutic agents for human diseasesGlutathione- and thioredoxin-related enzymes are modulated by sulfur-containing chemopreventive agentsIdentifying potent, selective protein tyrosine phosphatase inhibitors from a library of Au(I) complexes.On the mechanism and rate of gold incorporation into thiol-dependent flavoreductasesSynthesis and evaluation of 1,4-naphthoquinone ether derivatives as SmTGR inhibitors and new anti-schistosomal drugs.New trends for metal complexes with anticancer activityThe medicinal applications of imidazolium carbene-metal complexes.Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs.Phosphinogold(I) dithiocarbamate complexes: effect of the nature of phosphine ligand on anticancer properties.Zinc finger proteins as templates for metal ion exchange and ligand reactivity. Chemical and biological consequences.Advances in metal-carbene complexes as potent anti-cancer agents.Thioredoxin reductase and its inhibitors.Chemical biology of anticancer gold(III) and gold(I) complexes.Palladacycle promoted base controlled regio- and enantioselective hydrophosphination of 2-pyridylacrylate/amide and the cytotoxicity of their gold complexes.Highly cytotoxic bioconjugated gold(I) complexes with cysteine-containing dipeptides.Proteomic analysis of the cytotoxic effects induced by the organogold(III) complex Aubipyc in cisplatin-resistant A2780 ovarian cancer cells: further evidence for the glycolytic pathway implication.Gold(I) thiolates containing amino acid moieties. Cytotoxicity and structure-activity relationship studies.A cancer-targeted nanosystem for delivery of gold(III) complexes: enhanced selectivity and apoptosis-inducing efficacy of a gold(III) porphyrin complex.Recent developments in gold(I) coordination chemistry: luminescence properties and bioimaging opportunities.A binuclear gold(I) complex with mixed bridging diphosphine and bis(N-heterocyclic carbene) ligands shows favorable thiol reactivity and inhibits tumor growth and angiogenesis in vivo.Butyltin(IV) benzoates: inhibition of thioredoxin reductase, tumor cell growth inhibition, and interactions with proteins.Micelles based on gold-glycopolymer complexes as new chemotherapy drug delivery agents.In Silico Mining for Antimalarial Structure-Activity Knowledge and Discovery of Novel Antimalarial Curcuminoids.Resveratrol modulates mRNA transcripts of genes related to redox metabolism and cell proliferation in non-small-cell lung carcinoma cells.The Enzymatic and Structural Basis for Inhibition of Echinococcus granulosus Thioredoxin Glutathione Reductase by Gold(I).Gold(I) phosphine mediated selective inhibition of lymphoid tyrosine phosphataseProtein Recognition of Gold-Based Drugs: 3D Structure of the Complex Formed When Lysozyme Reacts with Aubipy(c.).Bioactive gold(i) complexes with 4-mercaptoproline derivatives.Double-Strand DNA Breaks Induced by Paracyclophane Gold(I) Complexes.Transition metal complexes with bioactive ligands: mechanisms for selective ligand release and applications for drug delivery.Dual targeting of the cancer antioxidant network with 1,4-naphthoquinone fused Gold(i) N-heterocyclic carbene complexes.On the biological properties of alkynyl phosphine gold(I) complexes.Cytotoxic gold(I) N-heterocyclic carbene complexes with phosphane ligands as potent enzyme inhibitors.Gold(III) complexes containing N-heterocyclic carbene ligands: thiol "switch-on" fluorescent probes and anti-cancer agents.
P2860
Q24652462-4FEF2073-F640-4A20-9930-3CEF5CF35F9AQ26800031-35ADB358-EE94-40E2-8C50-7CC6B109E807Q27686705-BE560842-F0A3-4D95-832F-EEF2D460D91CQ27687736-733CC3AC-A5EF-41AB-A960-2779D039D27CQ27695726-D58E14AD-326C-4975-8207-5E82C7D446D1Q27700978-5831ED4B-E3A8-4C82-9A71-3F80F3FC51D8Q28243207-743F6476-E68D-4A53-BD10-EA2A34133849Q28253359-F9A605C4-6F0E-4BCA-B935-8A13B2F6B365Q33514906-9E0B09CE-DA32-4755-92E7-1E3A23A1BF25Q36094494-4EAFF234-3870-40D2-A508-866D2BC37D1FQ36720951-0DB249A5-5B3C-4351-81A9-D27E70572BCCQ37044080-E84E7FA1-9BCB-450D-95E2-5E627E65BE8DQ37542176-D3EA5204-B778-4E7E-A5A5-78F8EA4C2D9DQ37603642-A382101A-F2A6-466B-9A5A-31548FF44A4FQ37714208-DE28B3D2-E1AF-4CF0-899E-FC8FCB96BC00Q37831171-E5F134FA-B0C1-4853-A5D7-5A50773F254AQ37949533-3144E93F-EE75-4CF9-8B1C-AA0C55541FC7Q38215943-13109B1F-EE49-4F1A-A530-70C495FBE4D9Q38418786-A2CC852D-B8FD-4A7E-8A0D-8C4D1C04ABBFQ38833790-89E0A1CD-5052-4A2B-8EF7-663483306D1BQ38860140-BF46073B-C0A0-4E27-819C-98769674E37BQ38883131-93BCED6C-FEDA-4E74-9C0A-17EF74F82B39Q38949131-CDF479AA-3D88-42DE-A3F2-DB6A9F65A470Q38956634-3A40F9F7-4EB1-403E-9AAF-DBF5AF3AB166Q38984457-4B9304D4-8952-4DC3-B4F5-051D245EF31BQ39004496-DB8588FB-DF21-4BD4-9B4E-67DE3CC2A6FEQ39217857-AD269352-9757-4BB6-A474-0BAC29384BCBQ39369895-A0C1229E-C971-4CE6-B2C8-C6442745BC2FQ39560559-203FA00E-2935-472D-98A4-2E58F9A41DBBQ40177661-9BEACB6B-9065-43A5-8A46-D726033931AFQ40229976-A9F971C7-A3A9-494D-9197-AD78AFD5D8D9Q40665987-AC5B697E-3F8E-4038-AEC6-0ED218D33FF0Q42936366-C1B98855-E861-4F80-BD6B-EDF74FF48AF0Q46504867-3AA56A8C-81B8-4EAB-A25A-E69036ECC627Q48280009-20377B35-229A-4B0F-B564-4655639BA591Q50803523-A8E1521C-12F5-4551-AB0A-1792EAFEF0D0Q52331600-87245F45-5523-425B-90A9-16F9B4B1F625Q52741196-3AA3793C-00C6-404F-8F3D-EC76B85B0A6BQ52768951-D6A73F65-0D57-4320-A99F-09F9FE50B5D3Q53699796-0EC52556-533F-4B96-879B-595FBEBA334F
P2860
Undressing of phosphine gold(I) complexes as irreversible inhibitors of human disulfide reductases.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Undressing of phosphine gold(I ...... of human disulfide reductases.
@en
type
label
Undressing of phosphine gold(I ...... of human disulfide reductases.
@en
prefLabel
Undressing of phosphine gold(I ...... of human disulfide reductases.
@en
P50
P356
P1476
Undressing of phosphine gold(I ...... of human disulfide reductases.
@en
P2093
Katalin Tóth
Sabine Urig
P304
P356
10.1002/ANIE.200502756
P407
P577
2006-03-01T00:00:00Z